Piergentili R, Marinelli E, Cucinella G, Lopez A, Napoletano G, Gullo G
Noncoding RNA. 2024; 10(2).
PMID: 38525735
PMC: 10961778.
DOI: 10.3390/ncrna10020016.
Hamam S, Abdelzaher E, Fadel S, Nassra R, Sharafeldin H
Childs Nerv Syst. 2023; 39(7):1869-1880.
PMID: 36892621
PMC: 10290605.
DOI: 10.1007/s00381-023-05899-z.
Abdolahi S, Zare-Chahoki A, Noorbakhsh F, Gorji A
Mol Neurobiol. 2022; 59(10):6260-6280.
PMID: 35916975
PMC: 9463196.
DOI: 10.1007/s12035-022-02966-5.
Laneve P, Caffarelli E
Front Cell Dev Biol. 2020; 8:275.
PMID: 32528946
PMC: 7266940.
DOI: 10.3389/fcell.2020.00275.
Lopez P, Girardi E, Mounce B, Weiss A, Chane-Woon-Ming B, Messmer M
J Virol. 2020; 94(9).
PMID: 32102877
PMC: 7163141.
DOI: 10.1128/JVI.02145-19.
Roles of TrkC Signaling in the Regulation of Tumorigenicity and Metastasis of Cancer.
Jin W
Cancers (Basel). 2020; 12(1).
PMID: 31936239
PMC: 7016819.
DOI: 10.3390/cancers12010147.
MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution.
Aravindan N, Subramanian K, Somasundaram D, Herman T, Aravindan S
Cancer Drug Resist. 2019; 2:1086-1105.
PMID: 31867575
PMC: 6924638.
DOI: 10.20517/cdr.2019.68.
miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S, Reynolds C, Pathania A, Gorantla S, Poluektova L, Coulter D
Mol Oncol. 2019; 14(1):180-196.
PMID: 31637848
PMC: 6944109.
DOI: 10.1002/1878-0261.12588.
Non-Coding RNAs in Pediatric Solid Tumors.
Smith C, Catchpoole D, Hutvagner G
Front Genet. 2019; 10:798.
PMID: 31616462
PMC: 6764412.
DOI: 10.3389/fgene.2019.00798.
Modulation of all-trans retinoic acid-induced MiRNA expression in neoplastic cell lines: a systematic review.
Lima L, de Melo T, Marques D, Goes de Araujo J, Leite I, Alves C
BMC Cancer. 2019; 19(1):866.
PMID: 31470825
PMC: 6717326.
DOI: 10.1186/s12885-019-6081-7.
Identification of serum exosomal microRNAs in acute spinal cord injured rats.
Ding S, Chen J, Wang S, Duan F, Chen Y, Shi Y
Exp Biol Med (Maywood). 2019; 244(14):1149-1161.
PMID: 31450959
PMC: 6802156.
DOI: 10.1177/1535370219872759.
Long Noncoding RNAs: Emerging Players in Medulloblastoma.
Laneve P, Rea J, Caffarelli E
Front Pediatr. 2019; 7:67.
PMID: 30923703
PMC: 6426782.
DOI: 10.3389/fped.2019.00067.
An agent for optical imaging of TrkC-expressing, breast cancer.
Kamkaew A, Li F, Li Z, Burgess K
Medchemcomm. 2018; 8(10):1946-1952.
PMID: 30108715
PMC: 6071931.
DOI: 10.1039/c7md00328e.
Identification of microRNA signature in different pediatric brain tumors.
Tantawy M, Elzayat M, Yehia D, Taha H
Genet Mol Biol. 2018; 41(1):27-34.
PMID: 29658967
PMC: 5901491.
DOI: 10.1590/1678-4685-GMB-2016-0334.
Small Molecules in Rare Tumors: Emerging Role of MicroRNAs in GIST.
Kupcinskas J
Int J Mol Sci. 2018; 19(2).
PMID: 29385688
PMC: 5855619.
DOI: 10.3390/ijms19020397.
Puerarin promotes the proliferation and differentiation of MC3T3-E1 cells via microRNA-106b by targeting receptor activator of nuclear factor-κB ligand.
Shan Z, Cheng N, Huang R, Zhao B, Zhou Y
Exp Ther Med. 2018; 15(1):55-60.
PMID: 29375675
PMC: 5766078.
DOI: 10.3892/etm.2017.5405.
Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets.
Kuznetsov V, Tang Z, Ivshina A
BMC Genomics. 2017; 18(Suppl 6):692.
PMID: 28984201
PMC: 5629558.
DOI: 10.1186/s12864-017-4027-5.
miRNA Enriched in Human Neuroblast Nuclei Bind the MAZ Transcription Factor and Their Precursors Contain the MAZ Consensus Motif.
Goldie B, Fitzsimmons C, Weidenhofer J, Atkins J, Wang D, Cairns M
Front Mol Neurosci. 2017; 10:259.
PMID: 28878619
PMC: 5573442.
DOI: 10.3389/fnmol.2017.00259.
Molecular mechanisms governing microRNA-125a expression in human hepatocellular carcinoma cells.
Potenza N, Panella M, Castiello F, Mosca N, Amendola E, Russo A
Sci Rep. 2017; 7(1):10712.
PMID: 28878257
PMC: 5587745.
DOI: 10.1038/s41598-017-11418-3.
11q deletion in neuroblastoma: a review of biological and clinical implications.
Mlakar V, Jurkovic Mlakar S, Lopez G, Maris J, Ansari M, Gumy-Pause F
Mol Cancer. 2017; 16(1):114.
PMID: 28662712
PMC: 5492892.
DOI: 10.1186/s12943-017-0686-8.